MedPath
TGA Approval

OGIVRI trastuzumab (rch) 150 mg powder for injection vial (288222)

288222

OGIVRI trastuzumab (rch) 150 mg powder for injection vial

Maxx Pharma Pty Ltd

December 11, 2018

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/a1811238de9d0e28753eaed58556131e.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/c6fe51b9645d0783b9b704e1b2d1a0fe.pdf

Active Ingredients

Trastuzumab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

OGIVRI trastuzumab (rch) 150 mg powder for injection vial (288222) - TGA 批准文号 | MedPath